as on November 15, 2025 at 2:29 am IST
Day's Low
Day's High
1.94%
Downside
0.51%
Upside
52 Week's Low
52 Week's High
31.14%
Downside
2.14%
Upside
Check Gilead Sciences Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$153.1B
EPS (TTM)
8.1695
Dividend Yield
3.74%
Quarterly Earnings Growth YOY
1.43%
PE Ratio (TTM)
19.07
Industry PE ratio
19.200384615384614
PEG Ratio
0.2242
EBITDA
14.1B
Revenue (TTM)
29.1B
Profit Margin
27.88%
Return On Equity TTM
40.71%
Track how Gilead Sciences Inc. P/E has moved over time to understand its valuation trends.
Gilead Sciences Inc. in the last 5 years
Lowest (7.99x)
September 30, 2021
Today (19.07x)
November 14, 2025
Industry (19.20x)
November 14, 2025
Highest (19.87x)
September 30, 2025
Today’s Price to Earnings Ratio: 19.07x
Compare market cap, revenue, PE, and other key metrics of Gilead Sciences Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| HOLD | $153.1B | 106.65% | 19.07 | 27.88% | |
| BUY | $910.9B | 618.41% | 49.96 | 30.99% | |
| BUY | $412.2B | 134.54% | 175.36 | 4.00% | |
| BUY | $468.3B | 30.25% | 18.8 | 27.26% | |
| BUY | $227.0B | 14.6% | 12.1 | 29.63% |
The Gilead Sciences Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Gilead Sciences Inc. investment value today
Current value as on today
₹1,40,949
Returns
₹40,949
(+40.95%)
Returns from Gilead Sciences Inc. Stock
₹35,707 (+35.71%)
Dollar Returns*
₹5,242 (+5.24%)
Based on 38 analysts
47.37%
Buy
52.63%
Hold
0.00%
Sell
Based on 38 analysts, 52.63% of analysts recommend a 'HOLD' rating for Gilead Sciences Inc.. Average target price of $129.91
Get share price movements and forecasts by analysts on Gilead Sciences Inc..
What analysts predicted
3.78%UPSIDE
Target Price
$129.91
Current Price
$125
Analyzed by
38 Analysts
Target
$129.91
Gilead Sciences Inc. target price $129.91, a slight upside of 3.78% compared to current price of $125. According to 38 analysts rating.
Investment in Gilead Sciences Inc. Shares on INDmoney has grown by 7.29% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:7.29%Â versus previous 30 day period
Search interest for Gilead Sciences Inc. Stock has decreased by -3% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 31 October
Fri, 07:50 PM
-Gilead reported Q3 2025 earnings, beating estimates but facing a decline in total product sales.
Fri, 08:00 PM
-Morgan Stanley raised Gilead's price target to $147, maintaining an Overweight rating amid strong HIV product trends.
Fri, 08:56 PM
-BMO Capital maintains Buy rating on Gilead, citing strong performance and future potential, especially in HIV treatments.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Gilead Sciences Inc. has shown strong profit growth over the last three quarters. The net profit increased from $1.31 billion to $3.05 billion, reflecting an average growth of 34.3% each quarter.
Revenue Rich
![]()
Gilead Sciences Inc. has shown positive revenue growth over the last three quarters. Their revenue increased from $6.66 billion to $7.76 billion, with an average quarterly increase of 7.4%. This consistent rise indicates a strong performance in their financial results.
Price Rise
![]()
In the last 7 days, GILD stock has moved up by 5.2%
Best in 1 Year
![]()
In the last 1 year, GILD has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 3 years, Eli Lilly And Company has given 53.0% return, outperforming this stock by 2.2%
| Organisation | Gilead Sciences Inc. |
| Headquarters | 333 Lakeside Drive, Foster City, CA, United States, 94404 |
| Industry | Health Technology |
| CEO | Mr. Daniel P. O'Day |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Andrew D. Dickinson | Chief Financial Officer |
Ms. Deborah H. Telman J.D. | Executive VP of Corporate Affairs, General Counsel & Corporate Secretary |
Ms. Johanna Mercier | Chief Commercial Officer |
Ms. Erin Burkhart | SVP, Controller & Principal Accounting Officer |
Dr. Flavius Martin M.D. | Executive Vice President of Research |
Ms. Janet Dorling | Senior Vice President of Intercontinental Region & Global Patient Solutions |
Mr. Daniel P. O'Day | Chairman & CEO |
Ms. Jacquie Ross C.F.A. | Senior Vice President of Treasury and Investor Relations |
Ms. Jyoti K. Mehra | Executive Vice President of Human Resources |
Dr. Linda Slanec Higgins Ph.D. | Senior Vice President of Research, Innovation & Portfolio |
Gilead Sciences Inc. share price today is $125 as on at the close of the market. Gilead Sciences Inc. share today touched a day high of $125.64 and a low of $122.57.
Gilead Sciences Inc. share touched a 52 week high of $127.68 on and a 52 week low of $86.08 on . Gilead Sciences Inc. stock price today i.e. is closed at $125,which is 2.10% down from its 52 week high and 45.21% up from its 52 week low.
Gilead Sciences Inc. market capitalisation is $0.15T as on .
Indian investors can start investing in Gilead Sciences Inc. (GILD) shares with as little as ₹88.74 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.40 in Gilead Sciences Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Gilead Sciences Inc. share’s latest price of $125 as on November 15, 2025 at 2:29 am IST, you will get 0.0800 shares of Gilead Sciences Inc.. Learn more about
fractional shares .
Gilead Sciences Inc. stock has given 106.65% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?